Stocks News

LAST PRICE
266.0500
TODAY'S CHANGE (%)
Trending Up4.9600 (1.8997%)

Bid / Lots
261.2500/ 5
Ask / Lots
274.8300/ 1
Open / Previous Close
263.8700 / 261.0900
Day Range
Low 260.4100
High 266.3800
52 Week Range
Low 204.4400
High 268.2100
Volume
474,260
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing, from 5:15PM ET on Wednesday May 08, 2024 by MT Newswires
  5:15PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: UTHR
  05:15 PM EDT, 05/08/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 07, 2024, sold 3,600 shares in United Therapeutics (UTHR) for $949,737. Following the Form 4 filing with the SEC, Rothblatt has control over a total ...
May 7, 2024
- United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing, from 5:00PM ET on Tuesday May 07, 2024 by MT Newswires
  5:00PM ET on Tuesday May 07, 2024 by MT Newswires
  Companies Mentioned: UTHR
  05:00 PM EDT, 05/07/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 03, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,871,233. Following the Form 4 filing with the SEC, Rothblatt has control over a tota...
May 6, 2024
- United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing, from 4:43PM ET on Monday May 06, 2024 by MT Newswires
  4:43PM ET on Monday May 06, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:43 PM EDT, 05/06/2024 (MT Newswires) -- Judy D. Olian, Director, on May 03, 2024, sold 10,000 shares in United Therapeutics (UTHR) for $2,585,601. Following the Form 4 filing with the SEC, Olian has control over a total of 7,305 shares of the com...
- United Therapeutics Insider Sold Shares Worth $582,195, According to a Recent SEC Filing, from 4:43PM ET on Monday May 06, 2024 by MT Newswires
  4:43PM ET on Monday May 06, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:43 PM EDT, 05/06/2024 (MT Newswires) -- Christopher Causey, Director, on May 03, 2024, sold 2,240 shares in United Therapeutics (UTHR) for $582,195. Following the Form 4 filing with the SEC, Causey has control over a total of 4,185 shares of the ...
May 3, 2024
- United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing, from 4:39PM ET on Friday May 03, 2024 by MT Newswires
  4:39PM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:39 PM EDT, 05/03/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 01, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,829,903. Following the Form 4 filing with the SEC, Rothblatt has control over a tota...

Yesterday
- Exact Sciences Q1 Net Loss Widens, Revenue Increases; 2024 Revenue Outlook Maintained -- Shares Fall After Hours, from 4:58PM ET on Wednesday May 08, 2024 by MT Newswires
  4:58PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: EXAS
- Medpace Holdings Insider Sold Shares Worth $21,129,347, According to a Recent SEC Filing, from 4:54PM ET on Wednesday May 08, 2024 by MT Newswires
  4:54PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: MEDP
- -- Earnings Flash (EXAS) EXACT SCIENCES Reports Q1 Revenue $637.5M, vs. Street Est of $626.8M, from 4:25PM ET on Wednesday May 08, 2024 by MT Newswires
  4:25PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: EXAS
- Exact Sciences Announces First-Quarter 2024 Results, from 4:05PM ET on Wednesday May 08, 2024 by Business Wire
  4:05PM ET on Wednesday May 08, 2024 by Business Wire
  Companies Mentioned: EXAS
- BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV, from 8:01AM ET on Wednesday May 08, 2024 by PR Newswire
  8:01AM ET on Wednesday May 08, 2024 by PR Newswire
  Companies Mentioned: BMRN
May 7, 2024
- Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW(R) 2024, from 8:00AM ET on Tuesday May 07, 2024 by Business Wire
  8:00AM ET on Tuesday May 07, 2024 by Business Wire
  Companies Mentioned: EXAS
May 6, 2024
- Biomarin Pharmaceutical Insider Sold Shares Worth $414,550, According to a Recent SEC Filing, from 4:47PM ET on Monday May 06, 2024 by MT Newswires
  4:47PM ET on Monday May 06, 2024 by MT Newswires
  Companies Mentioned: BMRN
May 4, 2024
- New Data for BioMarin's VOXZOGO(R) (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting, from 4:00PM ET on Saturday May 04, 2024 by PR Newswire
  4:00PM ET on Saturday May 04, 2024 by PR Newswire
  Companies Mentioned: BMRN
May 3, 2024
- Medpace Holdings Insider Sold Shares Worth $6,553,671, According to a Recent SEC Filing, from 4:13PM ET on Friday May 03, 2024 by MT Newswires
  4:13PM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: MEDP
May 1, 2024
- Medpace Holdings Insider Sold Shares Worth $6,782,987, According to a Recent SEC Filing, from 4:59PM ET on Wednesday May 01, 2024 by MT Newswires
  4:59PM ET on Wednesday May 01, 2024 by MT Newswires
  Companies Mentioned: MEDP

United Therapeutics Corp
NASDAQ:UTHRUnited States

Search Criteria

Yesterday

United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing, from 5:15PM ET on Wednesday May 08, 2024 by MT Newswires

May 7, 2024

United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing, from 5:00PM ET on Tuesday May 07, 2024 by MT Newswires

May 6, 2024

United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing, from 4:43PM ET on Monday May 06, 2024 by MT Newswires

United Therapeutics Insider Sold Shares Worth $582,195, According to a Recent SEC Filing, from 4:43PM ET on Monday May 06, 2024 by MT Newswires

May 3, 2024

United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing, from 4:39PM ET on Friday May 03, 2024 by MT Newswires

Peers Headlines

Yesterday

Exact Sciences Q1 Net Loss Widens, Revenue Increases; 2024 Revenue Outlook Maintained -- Shares Fall After Hours, from 4:58PM ET on Wednesday May 08, 2024 by MT Newswires

Medpace Holdings Insider Sold Shares Worth $21,129,347, According to a Recent SEC Filing, from 4:54PM ET on Wednesday May 08, 2024 by MT Newswires

-- Earnings Flash (EXAS) EXACT SCIENCES Reports Q1 Revenue $637.5M, vs. Street Est of $626.8M, from 4:25PM ET on Wednesday May 08, 2024 by MT Newswires

Exact Sciences Announces First-Quarter 2024 Results, from 4:05PM ET on Wednesday May 08, 2024 by Business Wire

BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV, from 8:01AM ET on Wednesday May 08, 2024 by PR Newswire

May 7, 2024

Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW(R) 2024, from 8:00AM ET on Tuesday May 07, 2024 by Business Wire

May 6, 2024

Biomarin Pharmaceutical Insider Sold Shares Worth $414,550, According to a Recent SEC Filing, from 4:47PM ET on Monday May 06, 2024 by MT Newswires

May 4, 2024

New Data for BioMarin's VOXZOGO(R) (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting, from 4:00PM ET on Saturday May 04, 2024 by PR Newswire

May 3, 2024

Medpace Holdings Insider Sold Shares Worth $6,553,671, According to a Recent SEC Filing, from 4:13PM ET on Friday May 03, 2024 by MT Newswires

May 1, 2024

Medpace Holdings Insider Sold Shares Worth $6,782,987, According to a Recent SEC Filing, from 4:59PM ET on Wednesday May 01, 2024 by MT Newswires